Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 28 October 2022 Biocartis Announces Conversion of a Portion of the Convertible Term Loan into New Shares and Discloses Outstanding Voting Securities Regulated information 28 October 2022 Invitation to the Extraordinary Shareholders’ Meeting Regulated information 27 October 2022 Results of the Extraordinary Shareholders’ Meeting held on 27 October 2022 Regulated information 21 October 2022 Biocartis Reports Results of Third Quarter of 2022 Inside information Regulated information 20 October 2022 Biocartis Announces First Drawdown of New Convertible Term Loans Regulated information 11 October 2022 Biocartis Announces Successful Amendment of its Existing Convertible Bonds Inside information Regulated information 10 October 2022 Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer Patients Non-regulated information 27 September 2022 Invitation to the Extraordinary Shareholders’ Meeting Regulated information 26 September 2022 Biocartis Announces Launch of Amendment Process and Exchange Offer for its Existing Convertible Bonds Regulated information 6 September 2022 Disclosure of outstanding voting securities Regulated information Pagination First page « First Previous page ‹‹ … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page ›› Last page Last »